Nilotinib ± Peg-IFN for First Line Chronic Phase CML Patients
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pazopanib in Molecularly Selected Patients With Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel
- Status
- WITHDRAWN
- Phase
- PHASE1
Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
A Prospective, Multicenter, Randomized, Open-label Study of 12 Week Duration to Evaluate the Effect of VILDagliptin Added to Insulin on Glycaemic Control in haemoDIALyzed Patients With Type 2 Diabetes: Probe Analysis of CGM
- Status
- COMPLETED
- Phase
- PHASE4
An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years
- Status
- TERMINATED
- Phase
- PHASE3
Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ranibizumab Treatment for Age-Related Macular Degeneretion
- Status
- UNKNOWN
- Phase
- NA
BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension
- Status
- COMPLETED
- Phase
- PHASE4
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE3
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
- Status
- COMPLETED
- Phase
- NA
LDE225 + Everolimus in Advanced Gastroesophageal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya
- Status
- COMPLETED
- Phase
- N/A
The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
- Status
- COMPLETED
- Phase
- PHASE3